Expectorants are pharmacological agents designed to assist in the removal of secretions from the respiratory tract. They achieve this by reducing the viscosity of mucus, making it easier to cough up phlegm from the trachea and bronchi. These drugs are frequently included in over-the-counter cough mixtures and formulations meant for productive coughs. Unlike cough suppressants, which block the cough reflex, expectorants promote productive coughing to clear the airways. In clinical settings across Nigeria, nurses encounter these medications commonly when caring for patients with acute upper respiratory tract infections.
The therapeutic effect of expectorants relies on direct or reflex stimulation of the respiratory tract.
Guaifenesin is currently the most widely available and accepted expectorant in clinical practice. Older agents like potassium iodide and ammonium chloride are used less frequently today due to their systemic side effect profiles and toxicity risks. Combination products often pair an expectorant with a decongestant, antihistamine, or antitussive. Nurses must read medication labels carefully to avoid duplicating active ingredients when patients take multiple multi-symptom cold preparations.
Expectorants are indicated for productive coughs associated with the common cold, acute bronchitis, influenza, and minor upper respiratory infections. When mucus is thick and difficult to expel, patients experience chest congestion and fatigue from coughing. Facilitating mucus clearance helps prevent secondary bacterial infections that thrive in stagnant pools of pulmonary secretions. They are generally not recommended for chronic conditions like COPD or asthma unless specifically directed by a physician.
Most expectorants are administered orally in tablet, capsule, or liquid syrup forms. Oral formulations are rapidly absorbed from the gastrointestinal tract with a relatively short half-life, requiring frequent dosing throughout the day. Adequate fluid intake is a mandatory accompaniment to expectorant therapy. Without sufficient systemic hydration, the chemical agents cannot effectively thin respiratory secretions, rendering the medication ineffective.
Expectorants are generally well tolerated, but minor adverse effects can occur. Gastrointestinal upset, nausea, and vomiting are occasionally reported, often linked to the gastric reflex mechanism of action. Dizziness and mild drowsiness may also affect ambulatory patients. Hypersensitivity reactions like skin rashes are rare. Contraindications include known allergies to specific ingredients and chronic persistent coughs associated with heart failure or smoking.
Before administering an expectorant, the nurse must assess the character of the patient's cough, sputum color, consistency, and amount. Auscultation of breath sounds reveals wheezes, crackles, or diminished air entry. Nurses should monitor the patient's temperature for signs of infection and check hydration status. Evaluating therapeutic effectiveness involves noting whether coughing has become more productive and if chest congestion is easing over time.
Comprehensive patient education ensures safe and effective drug therapy at home. Nurses must instruct patients to drink plenty of water throughout the day to support the medication's action. Patients should be warned not to use cough suppressants at the same time without medical advice, as trapping thinned mucus is dangerous. The nurse should advise reporting any cough lasting longer than a week or accompanied by high fever, chest pain, or blood-tinged sputum.